Biospring Partners

Biospring Partners is a dedicated, tech-enabled pharma services growth buyout firm. We invest in technology-enabled, EBITDA-positive B2B pharma services businesses in areas including outsourced complex biomanufacturing and outsourced clinical trials services. We focus exclusively on pharma services — deploying a hands-on approach to value creation and leveraging deep thematic research, an experienced operating team, and a proprietary sourcing platform. Our platform supports management teams with functional expertise across commercial, technical, and financial operations. We build conviction through years of direct engagement with biopharma, giving us a differentiated view into where the industry is heading—and what’s best positioned to serve patients. Biospring leverages our thematic work to identify high-potential companies and build multi-year relationships with management.